Cite Filings / EDSA / 0001193125-26-108289
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SCHEDULE 13G

Statement of Beneficial Ownership

Edesa Biotech, Inc. · Filed 2026-03-16 · Acc 0001193125-26-108289

Documents 1

  • SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X02/primary_doc.xml

Around this filing

  • 2026-05-15 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-03-16 SCHEDULE 13G Statement of Beneficial Ownership
  • 2026-03-11 4 President bought 2,000 shares at $1.57 ($3,140)
  • 2026-03-10 4 Chief Executive Officer bought 1,000 shares at $6.60 ($6,599)
  • 2026-03-03 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)

Stakes reported in this filing

Stake history · largest stake in each 13D and 13G

  1. 2026-11-16 SCHEDULE 13G · Boxer Capital Management, LLC 6.9%
  2. 2026-11-16 SCHEDULE 13G/A · Perceptive Advisors LLC 4.2%
  3. 2026-11-16 SCHEDULE 13G/A · Rubric Capital Management LP 4.61%
  4. 2026-11-16 SCHEDULE 13G · StemPoint Capital LP 9.9%
  5. 2026-11-16 SCHEDULE 13G/A · Sirenia Capital Management LP 9.9%
Loading xslSCHEDULE_13G_X02/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…